Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Pathology consultation on anticoagulation monitoring: factor X-related assays.
Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing--ASCEND I and II combined analysis.
McGuinn, Laura
Reversible amyloids of pyruvate kinase couple cell metabolism and stress granule disassembly.
Overview to Challenges in IBD 2024-2029.
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Overview to Challenges in IBD 2024-2029.
Overview to Challenges in IBD 2024-2029. Inflamm Bowel Dis. 2024 05 23; 30(Suppl 2):S1-S4.
View in:
PubMed
subject areas
Biomedical Research
Colitis, Ulcerative
Crohn Disease
Humans
Inflammatory Bowel Diseases
Precision Medicine
Quality of Life
authors with profiles
David Rubin